Sunovion Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SUNOVION, and what generic alternatives to SUNOVION drugs are available?
SUNOVION has one approved drug.
There are nine US patents protecting SUNOVION drugs.
There are sixty-two patent family members on SUNOVION drugs in twenty-four countries and nineteen supplementary protection certificates in sixteen countries.
Summary for Sunovion
International Patents: | 62 |
US Patents: | 9 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Patent Litigation for Sunovion: | See patent lawsuits for Sunovion |
Drugs and US Patents for Sunovion
Expired US Patents for Sunovion
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | 5,532,372*PED | ⤷ Try a Trial |
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | 9,815,827 | ⤷ Try a Trial |
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-003 | Dec 7, 2011 | 5,532,372*PED | ⤷ Try a Trial |
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-002 | Oct 28, 2010 | 5,532,372*PED | ⤷ Try a Trial |
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-004 | Apr 26, 2012 | 9,815,827 | ⤷ Try a Trial |
Sunovion Pharms Inc | LATUDA | lurasidone hydrochloride | TABLET;ORAL | 200603-005 | Jul 12, 2013 | 5,532,372*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SUNOVION drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg | ➤ Subscribe | 2014-10-28 |
International Patents for Sunovion Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 103180315 | ⤷ Try a Trial |
Canada | 2606510 | ⤷ Try a Trial |
Spain | 2326078 | ⤷ Try a Trial |
Australia | 2004259305 | ⤷ Try a Trial |
South Korea | 20130122019 | ⤷ Try a Trial |
Hungary | S1400051 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Sunovion Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1884242 | 2014/051 | Ireland | ⤷ Try a Trial | PRODUCT NAME: LURASIDONE, PARTICULARLY A PHARMACEUTICALLY ACCEPTABLE SALT FORM AND ESPECIALLY THE HYDROCHLORIDE SALT THEREOF; REGISTRATION NO/DATE: EU/1/14/913/001-021 20140321 |
1884242 | C20140030 00118 | Estonia | ⤷ Try a Trial | PRODUCT NAME: LURASIDOON;REG NO/DATE: K(2014)2046 (LOPLIK) 27.03.2014 |
1884242 | 251 5024-2014 | Slovakia | ⤷ Try a Trial | PRODUCT NAME: LURASIDON; REGISTRATION NO/DATE: EU/14/913/001 - EU/14/913/021 20140327 |
1884242 | 92550 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: LURASIDONE, FACULTATIVEMENT SOUS FORME DE SA BASE LIBRE OU DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES. FIRST REGISTRATION: 20140327 |
1884242 | C 2014 038 | Romania | ⤷ Try a Trial | PRODUCT NAME: LURASIDONA, OPTIONAL SUB FORMA BAZEI EI LIBERE SAU CA SARURIACCEPTABILE FARMACEUTIC ALREA (EEA): EU/1/14/913; DATE OF FIRST AUTHORISATION IN EEA: 20140321 E ACESTEIA, IN SPECIAL CLORHIDRAT DE LURASIDONA -C28H36N4O2S; NATIONAL AUTHORISATION NUMBER: EU/1/14/913; DATE OF NATIONAL AUTHORISATION: 20140321; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC A |
1884242 | CA 2014 00049 | Denmark | ⤷ Try a Trial | PRODUCT NAME: LURASIDON, EVENTUELT I FORM AF DEN FRIE BASE ELLER FARMACEUTISK ACCEPTABLE SALTE DERAF, HERUNDER LURASIDONHYDROCHLORID; REG. NO/DATE: EU/1/14/913/001-021 20140321 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.